Potential beneficiaries for whom these web pages were built

HIV-positive people and AIDS patients

Given the serious side effects of antiretroviral drug medicines for HIV/AIDS, it is high time that public awareness of the latest scientific evidence that the course of AIDS can be reversed naturally through the use of safe micronutrient supplements is improved. We therefore hope that the educational material on these pages, and on other sections of our website, will be of use to HIV-positive people, AIDS patients, and their families.

Government health departments

Prior to the publishing of the latest scientific evidence that the course of AIDS can be reversed naturally through the use of safe micronutrient supplements, government health departments effectively had no option in the treatment of this disease other than to use billions of dollars of taxpayers’ money for the purpose of purchasing antiretroviral drug medicines. We therefore hope that the material on these pages will be helpful in informing those responsible for the allocation of such resources that cheaper, safer and effective options for the control of HIV/AIDS are available.

Insurance companies

Because of the high costs of purchasing antiretroviral drug medicines, insurance companies should be interested in the latest scientific evidence that the course of AIDS can be reversed naturally through the use of safe micronutrient supplements as a means of reducing their exposure to such costs. Moreover, given that these drugs can cause serious side effects and that their efficacy is limited, there is clearly a need for insurance companies to consider these issues as an utmost priority.

Lawyers

As awareness grows regarding the serious side effects that can result from ARV treatment, class-action lawsuits will inevitably be brought against their manufacturers. For example, recent research suggests that some AIDS drugs – such as Abacavir and Didanosine – can dramatically increase the risk of heart attacks and that GlaxoSmithKline, the manufacturer of abacavir, had downplayed an early warning about the rising number of people who have suffered potentially fatal heart attacks following the use of the drug. As such, we hope that the material on these pages will be of interest to lawyers specialising in class-action lawsuits and the patients whose health and lives have been damaged by ARVs.